Pharmacological treatment options for mast cell activation disease

Mast cell activation disease (MCAD) is a term referring to a heterogeneous group of disorders characterized by aberrant release of variable subsets of mast cell (MC) mediators together with accumulation of either morphologically altered and immunohistochemically identifiable mutated MCs due to MC pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Molderings, Gerhard J., Haenisch, Britta, Brettner, Stefan, Homann, Jürgen, Menzen, Markus, Dumoulin, Franz Ludwig, Panse, Jens, Butterfield, Joseph, Afrin, Lawrence B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903110/
https://www.ncbi.nlm.nih.gov/pubmed/27132234
http://dx.doi.org/10.1007/s00210-016-1247-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4903110/
https://www.ncbi.nlm.nih.gov/pubmed/27132234
http://dx.doi.org/10.1007/s00210-016-1247-1

Ejemplares similares